How doctors stage and treat basal cell carcinoma
Part of Cancer clinical trials.
This study asks doctors how they stage and treat basal cell carcinoma, a common skin cancer. It aims to see if different doctors make different decisions, which could help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a doctor in a skin-related specialty like dermatology or plastic surgery.
- You have been certified in your specialty for at least one year.
- You currently treat people with basal cell carcinoma, a common type of skin cancer.
- You can fill out an online questionnaire within the study time frame.
- If you are a patient, you must be at least 18 years old with a confirmed basal cell carcinoma diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with advanced basal cell carcinoma (a type of skin cancer that is hard to treat or has spread) are cared for and what happens over time. It does not test any new treatments, but helps doctors learn more about the disease.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
This study tests a new imaging method called LC-OCT to look at basal cell carcinoma before Mohs surgery. It may help doctors see the tumor more clearly and plan the surgery better.
This study tests how well the immunotherapy medicine nivolumab works—either by itself or combined with other immune-boosting drugs—for people with advanced basal cell carcinoma that can’t be removed by surgery or has spread. It’s also looking at what to do if the cancer grows again after an earlier immunotherapy.
This trial tests a new drug (SP-002) combined with vismodegib for people with locally advanced basal cell carcinoma, a type of skin cancer that can't be treated with surgery or has come back after surgery. The goal is to see if this combination is safe and effective.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.